Entia Biosciences Inc (ERGO)
0.0002
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Entia Biosciences Net Income (Quarterly): -0.4328M for Dec. 31, 2016
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2016 | -0.4328M |
September 30, 2016 | -0.2888M |
June 30, 2016 | -0.4016M |
March 31, 2016 | -0.2726M |
December 31, 2015 | -0.3033M |
September 30, 2015 | -0.3669M |
June 30, 2015 | -1.069M |
March 31, 2015 | -0.5205M |
December 31, 2014 | -0.6921M |
September 30, 2014 | -0.5583M |
June 30, 2014 | -0.5108M |
March 31, 2014 | -0.5354M |
December 31, 2013 | -1.104M |
September 30, 2013 | -0.5107M |
June 30, 2013 | -1.038M |
March 31, 2013 | -0.4535M |
December 31, 2012 | -0.2895M |
September 30, 2012 | -0.2808M |
Date | Value |
---|---|
June 30, 2012 | -0.3721M |
March 31, 2012 | -0.3218M |
December 31, 2011 | -0.6342M |
September 30, 2011 | -0.2008M |
June 30, 2011 | -0.2112M |
March 31, 2011 | -0.6829M |
December 31, 2010 | -0.3441M |
September 30, 2010 | -0.4288M |
June 30, 2010 | -0.2665M |
March 31, 2010 | -0.3018M |
December 31, 2009 | -0.5024M |
September 30, 2009 | -0.189M |
June 30, 2009 | -0.0859M |
March 31, 2009 | -0.1496M |
December 31, 2008 | -0.0951M |
September 30, 2008 | -0.0166M |
July 31, 2008 | -0.005M |
April 30, 2008 | -0.0015M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Ampio Pharmaceuticals Inc | -2.054M |
FluoroPharma Medical Inc | -0.1272M |
Evolutionary Genomics Inc | -0.3338M |
Xeno Transplants Corp | -- |
Regenerx Biopharmaceuticals Inc | -0.3852M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.046M |
Total Expenses (Quarterly) | 0.4316M |
EPS Diluted (Quarterly) | -0.02 |